use of a single random serum progesterone value as a diagnostic aid for ectopic pregnancy: gilder...

1
Abstracts in this issue were prepared by residents in the Universityof Arizona Emergency Medicine Residency Program. ABSTRACTS Richard Dart, MD Co-Editor Section of Emergency Medicine University of Arizona College of Medicine Tucson, Arizona Vincent J Markovchick, MD, FACEP Co-Editor Emergency Medical Services Denver General Hospital Denver, Colorado William A Robinson, MD, FACEP Co-Editor Department of Emergency Medicine University of Missouri-Kansas City School of Medicine Kansas City, Missouri intubation, endotracheal Which drug prevents tachycardia and hypertension associated with tracheal intubation: Lidocaine, fentanyl, or esmolol? Helfman SM, Gold MI, DeLisser EA, et al Anesthes Analg 72:482-486 Apr 1991 This study attempted to determine if a single bolus of placebo, lidocaine, fentanyl, or esmolol has a significant effect on a patient's hemodynamic response to endotracheal intubation. Patients were more than 21 years old; ASA II-IV; scheduled for noncardiac surgery; had no history of greater than first-degree atrioventricular block or of congestive heart fail- ure; had no history of cardiac ar- rhythmias; and had not taken beta- blockers within 24 hours prior to sur- gery. Patients were pretreated with glycopyrrolate and midazolam 30 to 60 minutes before induction. Oxygen and thiopental were administered in the operating room, followed by the study drug (placebo, lidocaine 200 rag, fentanyl 200 pog, or esmolol 150 mg). Succinylcholine was given at one minute followed by intubation. All patients were intubated by the same person. Intubations taking more than 30 seconds were excluded from the study. Heart rate was taken every 15 seconds, and systolic blood pressure was taken every minute for ten minutes after intubation. The re- sults showed that the increases in heart rate were the same for the pla- cebo, lidocaine, and fentanyl groups, but were lower in the esmolol group. Systolic blood pressure and changes in systolic blood pressure were lower in the three drug groups than the pla- cebo group but showed no intergroup differences. The authors conclude that the use of esmolol before intuba- tion should be considered when there is worry about the hemodynamic response to intubation. Jeff Schaffer, MD pregnancy, ectopic; progesterone Use of a single random serum progesterone value as a diagnostic aid for ectopic pregnancy Gilder MS, Boots LR, Younger JB Fertil Steril 55:497-500 Mar 1991 The authors retrospectively evalu- ated random serum progesterone levels from 126 pregnant patients to assess the value of a single random serum progesterone value in the diag- nosis of ectopic pregnancy. Preg- nancy was initially determined by at least two successive serum ~3-HCG levels. Patients were divided into three groups based on pregnancy out- come, including intrauterine preg- nancy, ectopic pregnancy, or abnor- mal intrauterine pregnancy (sponta- neous or missed abortion, blighted ova). All patients had at least two serum samples assayed for pro- gesterone between three and ten weeks' gestation, and all values ob- tained for each group during this time interval were averaged. Al- though significant differences of mean values for all three groups were identified, there was no single pro- gesterone value that predicted the presence or absence of ectopic preg- nancy due to the considerable over- lap in the range of values. Of the pa- tients with ectopic pregnancy, only 2% had a progesterone value of more than 20 mg/mL, and only 2% of pa- tients with intrauterine pregnancy had a value of less than 10 mg/mL. The authors conclude that the usefulness of a single random pro- gesterone value in the diagnosis of ectopic pregnancy remains unproven. Mark Mahoney, MD Annalsof EmergencyMedicine deferoxamine; chelation An objective criterion for the cessation of deferoxamine therapy in the acutely poisoned patient Yatscoff RW, Wayne EA, Tenenbein M C/in Toxieo/ 29:1-10 Mar 1991 There are no clear end points for discontinuation of deferoxamine therapy in patients with iron poison- ing. The purpose of this study was to develop an objective end point for chelation therapy. Most methods for quickly determining iron in fluids are confounded by the presence of de- feroxamine. The authors adapted and validated a method for iron deter- mination in urine in the presence of deferoxamine. Urine was collected from 20 healthy volunteers at two- hour intervals for a total of 24 hours on day 1, and iron and creatinine were measured in each sample. The ratio of iron to creatinine (Fe:Cr) was calculated, thereby giving a measure that was independent of urine flow. On day 2, urine samples were again collected, this time during and after a 15 mg/kg/hr infusion of deferox- amine over two hours. The mean Fe:Cr ratios calculated on day 1 (2.78 _+ 3.1) and day 2 (3.36 + 3.7) were not statistically different. The Fe:Cr ratio greater than the 97.5th percent- ile (12.5) was chosen in these normal subjects as an indicator of increased ferruresis. The Fe:Cr ratios in three iron-poisoned patients were found to be greater than i2.5 during the de- feroxamine infusion. Less than half of the urine samples were colored at times when the Fe:Cr ratio was greater than 12.5. The authors con- clude that the assay is accurate and reliable; during an infusion of de- feroxamine the Fe:Cr ratio provides an objective end point for termina- tion of therapy (the end point ratio of 12.5 is based on the above infusion 20:10 October 1991 1163/161

Upload: mark-mahoney

Post on 02-Jul-2016

215 views

Category:

Documents


3 download

TRANSCRIPT

Abstracts in this issue were prepared by residents in the University of Arizona Emergency Medicine Residency Program.

ABSTRACTS Richard Dart, MD Co-Editor Section of Emergency Medicine University of Arizona College of Medicine Tucson, Arizona

Vincent J Markovchick, MD, FACEP Co-Editor Emergency Medical Services Denver General Hospital Denver, Colorado

William A Robinson, MD, FACEP Co-Editor Department of Emergency Medicine University of Missouri-Kansas City

School of Medicine Kansas City, Missouri

intubation, endotracheal

Which drug prevents tachycardia and hypertension associated with t racheal intubation: Lidocaine, fentanyl , or esmolol? Helfman SM, Gold MI, DeLisser EA, et al Anesthes Analg 72:482-486 Apr 1991

This s tudy a t t empted to de te rmine if a single bolus of placebo, l idocaine, fentanyl, or esmolol has a significant effect on a p a t i e n t ' s h e m o d y n a m i c response to endotracheal in tubat ion. Pat ients were more than 21 years old; ASA II-IV; scheduled for noncardiac surgery; had no h i s t o r y of g rea te r t h a n f i r s t - d e g r e e a t r i o v e n t r i c u l a r b l o c k or of c o n g e s t i v e h e a r t fa i l - ure; had no h i s t o ry of ca rd iac ar- rhythmias ; and had not taken beta- blockers wi th in 24 hours prior to sur- gery. Pa t ien ts were pre t rea ted w i th glycopyrrolate and midazo lam 30 to 60 minu tes before induct ion. Oxygen and th iopenta l were adminis te red in the operat ing room, followed by the s tudy drug (placebo, l i d o c a i n e 200 rag, fentanyl 200 pog, or esmolol 150 mg). S u c c i n y l c h o l i n e was g iven at one m i n u t e fo l lowed by in tuba t ion . Al l pa t ien ts were i n tuba t ed by the s a m e pe r son . I n t u b a t i o n s t a k i n g more than 30 seconds were excluded from the study. Heart rate was taken every 15 seconds, and systol ic blood pressure was taken every minu t e for ten minu tes after intubat ion. The re- su l t s showed tha t the inc reases in hear t rate were the same for the pla- cebo, lidocaine, and fentanyl groups, but were lower in the esmolol group. Systol ic blood pressure and changes in systol ic blood pressure were lower in the three drug groups than the pla- cebo group but showed no intergroup d i f f e r ences . The au tho r s c o n c l u d e tha t the use of esmolol before intuba- t ion should be considered when there

is w o r r y a b o u t t he h e m o d y n a m i c response to intubat ion.

Jeff Schaffer, MD

pregnancy, ectopic; progesterone

Use of a single random serum progesterone value as a diagnost ic aid for ectopic pregnancy Gilder MS, Boots LR, Younger JB Fertil Steril 55:497-500 Mar 1991

The authors re t rospect ively evalu- a t e d r a n d o m s e r u m p r o g e s t e r o n e levels from 126 pregnant pat ients to assess the value of a single random serum progesterone value in the diag- n o s i s of e c t o p i c p r e gna nc y . Preg- nancy was in i t ia l ly de termined by at least two success ive se rum ~3-HCG leve l s . P a t i e n t s were d i v i d e d i n to three groups based on pregnancy out- come, i n c l u d i n g i n t r a u t e r i n e preg- nancy, ec top ic pregnancy, or abnor- mal i n t r au te r ine pregnancy (sponta- neous or missed abor t ion, b l igh ted ova). Al l p a t i e n t s had at l eas t two s e r u m s a m p l e s a s s a y e d for p ro - g e s t e r o n e b e t w e e n t h r e e and t e n weeks ' ges ta t ion, and all va lues ob- t a i n e d for each group d u r i n g th i s t i m e i n t e r v a l w e r e a v e r a g e d . Al - t h o u g h s i g n i f i c a n t d i f f e r e n c e s of mean values for all three groups were ident i f ied, there was no single pro- ges t e rone va lue tha t p r e d i c t e d the presence or absence of ectopic preg- nancy due to the considerable over- lap in the range of values. Of the pa- t i en ts w i th ec topic pregnancy, only 2% had a progesterone value of more than 20 mg/mL, and only 2% of pa- t i en t s w i t h i n t r a u t e r i n e p r egnancy had a value of less than 10 mg/mL. T h e a u t h o r s c o n c l u d e t h a t t h e usefu lness of a single r andom pro- ges terone va lue in the diagnosis of ectopic pregnancy remains unproven.

Mark Mahoney, MD

Annals of Emergency Medicine

deferoxamine; chelation

An object ive cr i ter ion for the cessat ion of deferoxamine therapy in the acute ly poisoned pat ient Yatscoff RW, Wayne EA, Tenenbein M C/in Toxieo/ 29:1-10 Mar 1991

There are no clear end po in t s for d i s c o n t i n u a t i o n of d e f e r o x a m i n e therapy in pat ients w i th iron poison- ing. The purpose of this s tudy was to deve lop an ob jec t ive end p o i n t for chela t ion therapy. Most methods for q u i c k l y d e t e r m i n i n g i ron in f lu ids are confounded by the presence of de- feroxamine. The authors adapted and va l i da t ed a m e t h o d for i ron deter- mina t ion in ur ine in the presence of de fe roxamine . U r i n e was co l l ec t ed f rom 20 he a l t hy vo lun tee r s at two- hour intervals for a total of 24 hours on day 1, and i ron and c r e a t i n i n e were measured in each sample. The ratio of iron to creat inine (Fe:Cr) was calculated, thereby giving a measure that was independent of ur ine flow. On day 2, urine samples were again collected, this t ime during and after a 15 m g / k g / h r i n f u s i o n of d e f e r o x - a m i n e over two hours . The m e a n Fe:Cr rat ios calculated on day 1 (2.78 _+ 3.1) and day 2 (3.36 + 3.7) were not s ta t i s t ica l ly different. The Fe:Cr rat io greater than the 97.5th percent- ile (12.5) was chosen in these normal subjects as an indicator of increased ferruresis. The Fe:Cr ratios in three i ron-poisoned pat ients were found to be greater than i2.5 dur ing the de- fe roxamine infusion. Less than half of the ur ine samples were colored at t i m e s w h e n the F e : C r r a t i o was greater than 12.5. The authors con- clude that the assay is accurate and re l iab le ; dur ing an i n fus ion of de- fe roxamine the Fe:Cr ra t io provides an objec t ive end po in t for t e rmina- t ion of therapy (the end point ratio of 12.5 is based on the above infusion

20:10 October 1991 1163/161